Journal Mobile Options
Table of Contents
Vol. 41, No. 5, 2008
Issue release date: August 2008
Psychopathology 2008;41:271–278

Definitions of the Term ‘Recovered’ in Schizophrenia and Other Disorders

Færden A. · Nesvåg R. · Marder S.R.
aDepartment of Psychiatric Research, Ullevål University Hospital, and bDepartment of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway; cSemel Institute for Neuroscience at UCLA, Los Angeles, Calif., USA

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Background: The use of the term ‘recovered’ in outcome studies of schizophrenia has for a long time been problematic because of the many different definitions in use. In the present study different definitions of recovered in schizophrenia are reviewed and compared with similar definitions in other fields of medicine. Sampling and Methods: A literature searchwas done for criteria-based definitions of recovered as used in follow-up studies of patients with schizophrenia during the last 50 years and the current use of the term in other fields of medicine. Results: In medicine, only the field of psychiatry defines the term recovered to be synonymous with no or minimal signs of illness. Other fields only apply the term when studying the outcome of a specific function. In psychiatry, only the field of schizophrenia includes both symptoms and functioning in the definition. All but 1 of the 18 definitions found in use in the field of schizophrenia required minimal or no symptoms, while all differed in defining functional recovery. Recovered was seldom defined as following from a state of remission, and studies varied in requiring a stable phase. Conclusion: When using the term in the field of schizophrenia, a distinction should be made between symptomatic and functional recovery in order to place it in line with other fields of medicine. To avoid confusing the process of recovery from the state of being recovered, the term recovered should be reserved for use in outcome studies, following from a time in remission. We suggest 2 years.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Stephens JH: Long-term prognosis and follow-up in schizophrenia. Schizophr Bull 1978;4:25–47.
  2. McGlashan TH: A selective review of recent North American long-term follow-up studies of schizophrenia. Schizophr Bull 1988;14:515–542.
  3. Warner R: Recovery from Schizophrenia, ed 2. London, Routledge, 1994.
  4. World Health Organization: Schizophrenia. An International Follow-Up Study. Chichester, Wiley & Sons, 1979.
  5. Andreasen NC, Carpenter WT Jr, Kane JM, Lasser RA, Marder SR, Weinberger DR: Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry 2005;162:441–449.
  6. Van Os J, Drukker M, Campo J, Meijer J, Bak M, Delespaul P: Validation of remission criteria for schizophrenia. Am J Psychiatry 2006;163:2000–2002.
  7. Wunderink L, Nienhuis FJ, Sytema S, Wiersma D: Predictive validity of proposed remission criteria in first-episode schizophrenic patients responding to antipsychotics. Schizophr Bull 2007;33:792–796.
  8. Oosthuizen P, Emsley R, Niehaus D, Koen L, Chiliza B: The relationships between depression and remission in first-episode psychosis. World Psychiatry 2006;5:172–176.
  9. Lasser RA, Bossie CA, Gharabawi GM, Kane JM: Remission in schizophrenia: results from a 1-year study of long-acting risperidone injection. Schizophr Res 2005;77:129–139.
  10. Kraepelin E: Dementia Praecox and Paraphrenia, ed reprint 1919 English translated edition. Huntington, Krieger, 1971.
  11. Bleuler E: Dementia Preacox or the Group of Schizophrenias. New York, International Universities Press, 1950.
  12. Harding CM, Brooks GW, Ashikaga T, Strauss JS, Breier A: The Vermont longitudinal study of persons with severe mental illness. II. Long-term outcome of subjects who retrospectively met DSM-III criteria for schizophrenia. Am J Psychiatry 1987;144:727–735.
  13. Anthony WA: Recovery from mental illness: the guiding vision of the mental health service system in the 1990s. Psychosoc Rehabil J 1993;16:11–23.
  14. Jacobson N, Greenley D: What is recovery? A conceptual model and explication. Psychiatr Serv 2001;52:482–485.
  15. Struening EL, Perlick DA, Link BG, Hellman F, Herman D, Sirey JA: Stigma as a barrier to recovery: the extent to which caregivers believe most people devalue consumers and their families. Psychiatr Serv 2001;52:1633–1638.
  16. Davidson L, O’Connell M, Tondora J, Styron T, Kangas K: The top ten concerns about recovery encountered in mental health system transformation. Psychiatr Serv 2006;57:640–645.
  17. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders DSM IV, ed 4. Washington, American Psychiatric Association, 1994.
  18. Liberman R, Kopelowicz AJ, Gutkind D: Operational criteria and factors related to recovery from schizophrenia. Int J Psychiatry 2002;14:256–272.

    External Resources

  19. Rund BR: Fully recovered schizophrenics: a retrospective study of some premorbid and treatment factors. Psychiatry 1990;53:127–139.
  20. Torgalsboen AK: Full recovery from schizophrenia: the prognostic role of premorbid adjustment, symptoms at first admission, precipitating events and gender. Psychiatry Res 1999;88:143–152.
  21. Vaillant GE: The prediction of recovery in schizophrenia. J Nerv Ment Dis 1962;135:534–543.
  22. Bleuler M: The Schizophrenia Disorders. Long-term Patient and Family Studies. New Haven, Yale University Press, 1978.
  23. McGlashan TH: The Chestnut Lodge follow-up study. II. Long-term outcome of schizophrenia and the affective disorders. Arch Gen Psychiatry 1984;41:586–601.
  24. Marengo J, Harrow M, Sands J, Galloway C: European versus US data on the course of schizophrenia. Am J Psychiatry 1991;148:606–611.
  25. Tsuang D, Coryell W: An 8-year follow-up of patients with DSM-III-R psychotic depression, schizoaffective disorder, and schizophrenia. Am J Psychiatry 1993;150:1182–1188.
  26. Tohen M, Strakowski SM, Zarate C Jr, Hennen J, Stoll AL, Suppes T, Faedda GL, Cohen BM, Gebre-Medhin P, Baldessarini RJ: The McLean-Harvard first-episode project: 6-month symptomatic and functional outcome in affective and nonaffective psychosis. Biol Psychiatry 2000;48:467–476.
  27. Harrison G, Hopper K, Craig T, Laska E, Siegel C, Wanderling J, Dube KC, Ganev K, Giel R, an der Heiden W, Holmberg SK, Janca A, Lee PW, Leon CA, Malhotra S, Marsella AJ, Nakane Y, Sartorius N, Shen Y, Skoda C, Thara R, Tsirkin SJ, Varma VK, Walsh D, Wiersma D: Recovery from psychotic illness: a 15- and 25-year international follow-up study. Br J Psychiatry 2001;178:506–517.
  28. Whitehorn D, Brown J, Richard J, Rui Q, Kopala L: Multiple dimensions of recovery in early psychosis. Int Rev Psychiatry 2002;14:273–282.

    External Resources

  29. Modestin J, Huber A, Satirli E, Malti T, Hell D: Long-term course of schizophrenic illness: Bleuler’s study reconsidered. Am J Psychiatry 2003;160:2202–2208.
  30. Robinson DG, Woerner MG, McMeniman M, Mendelowitz A, Bilder RM: Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder. Am J Psychiatry 2004;161:473–479.
  31. Lauronen E, Koskinen J, Veijola J, Miettunen J, Jones PB, Fenton WS, Isohanni M: Recovery from schizophrenic psychoses within the northern Finland 1966 Birth Cohort. J Clin Psychiatry 2005;66:375–383.
  32. Harrow M, Grossman LS, Jobe TH, Herbener ES: Do patients with schizophrenia ever show periods of recovery? A 15-year multi-follow-up study. Schizophr Bull 2005;31:723–734.
  33. Xie H, McHugo GJ, Helmstetter BS, Drake RE: Three-year recovery outcomes for long-term patients with co-occurring schizophrenic and substance use disorders. Schizophr Res 2005;75:337–348.
  34. Hammond FM, Grattan KD, Sasser H, Corrigan JD, Bushnik T, Zafonte RD: Long-term recovery course after traumatic brain injury: a comparison of the functional independence measure and disability rating scale. J Head Trauma Rehabil 2001;16:318–329.
  35. Viosca E, Lafuente R, Martinez JL, Almagro PL, Gracia A, Gonzalez C: Walking recovery after an acute stroke: assessment with a new functional classification and the Barthel Index. Arch Phys Med Rehabil 2005;86:1239–1244.
  36. Meireles GC, Lemos PA, Ambrose JA, Ribeiro E, Horta PE, Perin M, Ramires JA, Martinez EE: Luminal recovery from six to twelve months after implantation of thicker strut coronary stents. Am J Cardiol 2004;93:210–213.
  37. Mulder RT, Joyce PR, Frampton CM, Luty SE, Sullivan PF: Six months of treatment for depression: outcome and predictors of the course of illness. Am J Psychiatry 2006;163:95–100.
  38. Posternak MA, Solomon DA, Leon AC, Mueller TI, Shea MT, Endicott J, Keller MB: The naturalistic course of unipolar major depression in the absence of somatic therapy. J Nerv Ment Dis 2006;194:324–329.
  39. Nierenberg AA, Ostacher MJ, Calabrese JR, Ketter TA, Marangell LB, Miklowitz DJ, Miyahara S, Bauer MS, Thase ME, Wisniewski SR, Sachs GS: Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone. Am J Psychiatry 2006;163:210–216.
  40. Perlis RH, Ostacher MJ, Patel JK, Marangell LB, Zhang H, Wisniewski SR, Ketter TA, Miklowitz DJ, Otto MW, Gyulai L, Reilly-Harrington NA, Nierenberg AA, Sachs GS, Thase ME: Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry 2006;163:217–224.
  41. Conus P, Cotton S, Abdel-Baki A, Lambert M, Berk M, McGorry PD: Symptomatic and functional outcome 12 months after a first episode of psychotic mania: barriers to recovery in a catchment area sample. Bipolar Disord 2006;8:221–231.
  42. Bruce SE, Yonkers KA, Otto MW, Eisen JL, Weisberg RB, Pagano M, Shea MT, Keller MB: Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study. Am J Psychiatry 2005;162:1179–1187.
  43. Vriends N, Becker ES, Meyer A, Williams SL, Lutz R, Margraf J: Recovery from social phobia in the community and its predictors: data from a longitudinal epidemiological study. J Anxiety Disord 2007;21:320–337.
  44. Wagner A, Barbarich-Marsteller NC, Frank GK, Bailer UF, Wonderlich SA, Crosby RD, Henry SE, Vogel V, Plotnicov K, McConaha C, Kaye WH: Personality traits after recovery from eating disorders: do subtypes differ? Int J Eat Disord 2006;39:276–284.
  45. Frank E, Prien RF, Jarrett RB, Keller MB, Kupfer DJ, Lavori PW, Rush AJ, Weissman MM: Conceptualization and rationale for consensus definitions of terms in major depressive disorder: remission, recovery, relapse, and recurrence. Arch Gen Psychiatry 1991;48:851–855.
  46. Field AE, Herzog DB, Keller MB, West J, Nussbaum K, Colditz GA: Distinguishing recovery from remission in a cohort of bulimic women: how should asymptomatic periods be described? J Clin Epidemiol 1997;50:1339–1345.
  47. Keller MB: Past, present, and future directions for defining optimal treatment outcome in depression: remission and beyond. JAMA 2003;289:3152–3160.
  48. Gove PB, Merriam-Webster Editorial Staff: Webster’s Third New International Dictionary, ed 3. Springfield, Merriam-Webster, 1993.
  49. Andresen R, Oades L, Caputi P: The experience of recovery from schizophrenia: towards an empirically validated stage model. Aust NZ J Psychiatry 2003;37:586–594.
  50. Liberman RP, Kopelowicz A: Recovery from schizophrenia: a concept in search of research. Psychiatr Serv 2005;56:735–742.
  51. Drury V, Birchwood M, Cochrane R, Macmillan F: Cognitive therapy and recovery from acute psychosis: a controlled trial. II. Impact on recovery time. Br J Psychiatry 1996;169:602–607.
  52. Torrey WC, Wyzik P: The recovery vision as a service improvement guide for community mental health center providers. Community Mental Health J 2000;36:209–216.
  53. Link BG, Struening EL, Neese-Todd S, Asmussen S, Phelan JC: Stigma as a barrier to recovery: the consequences of stigma for the self-esteem of people with mental illnesses. Psychiatr Serv 2001;52:1621–1626.
  54. Davidson L, O’Connell M, Tondora J, Styron T, Kangas K: The top ten concerns about recovery encountered in mental health system transformation. Psychiatr Serv 2006;57:640–645.
  55. Heiss WD, Teasel RW: Brain recovery and rehabilitation. Stroke 2006;37:314–316.
  56. Behrman AL, Bowden MG, Nair PM: Neuroplasticity after spinal cord injury and training: an emerging paradigm shift in rehabilitation and walking recovery. Phys Ther 2006;86:1406–1425.
  57. Carpenter WT Jr, Strauss JS: The prediction of outcome in schizophrenia. IV. Eleven-year follow-up of the Washington IPSS cohort. J Nerv Ment Dis 1991;179:517–525.
  58. Green MF: What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 1996;153:321–330.
  59. Harding CM, Zubin J, Strauss JS: Chronicity in schizophrenia: fact, partial fact, or artifact? Hosp Community Psychiatry 1987;38:477–486.
  60. Couturier J, Lock J: What is recovery in adolescent anorexia nervosa? Int J Eat Disord 2006;39:550–555.
  61. Wiersma D, Nienhuis FJ, Slooff CJ, Giel R: Natural course of schizophrenic disorders: a 15-year follow-up of a Dutch incidence cohort. Schizophr Bull 1998;24:75–85.
  62. Addington D, Addington J, Patten S: Relapse rates in an early psychosis treatment service. Acta Psychiatr Scand 2007;115:126–131.
  63. Torgalsboen A, Rund B: Lessons learned from three studies of recovery from schizophrenia. Int Rev Psychiatry 2002;14:312–317.

    External Resources

  64. Van Riel PL, Fransen J: To be in remission or not: is that the question? Ann Rheum Dis 2005;64:1389–1390.
  65. Cooney RM, Warren BF, Altman DG, Abreu MT, Travis SP: Outcome measurement in clinical trials for ulcerative colitis: towards standardisation. Trials 2007;8:17.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50